Note 2 - Acquisitions (Tables)

9 Months Ended

Mar. 31, 2015

	Novus		ProteinSimple		CyVek

Current assets	$	10,739	$	20,273	$	945
Equipment		1,266		1,983		971
Other long-term assets		40		554		19
Intangible Assets:
Developed technology		5,010		40,500		20,200
Trade name		5,300		35,800		100
Customer relationships		14,400		100,600		900
Non-compete agreements		-		200		-
Goodwill		26,692		134,265		91,584
Total assets acquired		63,447		334,175		114,719

Liabilities		2,166		11,304		1,930
Deferred income taxes, net		1,159		22,818		(438	)
Net assets	$	60,122	$	300,053	$	113,227
Less fair-value of previous investment		-		-		18,300
Net assets acquired		60,122		300,053		94,927

Cash paid, net of cash acquired	$	60,122	$	300,053		59,927
Contingent consideration payable		-		-		35,000
Net purchase price	$	60,122	$	300,053	$	94,927

	Novus						ProteinSimple						CyVek
	Quarter Ended			Nine Months Ended			Quarter Ended			Nine Months Ended			Quarter Ended			Nine Months Ended
	March 31, 2015			March 31, 2015			March 31, 2015			March 31, 2015			March 31, 2015			March 31, 2015

Net sales	$	4,845		$	15,438		$	20,414		$	53,427		$	192		$	392
Net (loss) income		(76	)		(430	)		(4,545	)		(5,753	)		(2,601	)		(3,624	)
Amortization expense		474			1,423			2,951			8,325			374			625
Cost recognized on sale of acquired inventory		406			1,465			-			1,444			-			64